@article{ref1,
title="Natural snake venom inhibitors and their pharmaceutical uses: challenges and possibilities",
journal="Current pharmaceutical design",
year="2018",
author="Saavedra, Soledad Lorena and Avila, Lucia and Giudicessi, Silvana Laura and Albericio, Fernando and Camperi, Silvia Andrea and Cascone, Osvaldo and Martinez-Ceron, Maria Camila",
volume="24",
number="16",
pages="1737-1747",
abstract="Nowadays, treatment with specific antivenins is considered the only cure for snakebites accidents. However, access to antivenom obstructs the successful implementation of the World Health Organization international guidelines. In the last few years, natural organic compounds, peptides and proteins with the ability to inhibit snake toxins and obtained from different sources such as plant extracts and animal blood have been proposed as antivenoms. In this work, we will focus on the inhibitors of the main venom toxins, phospholipases A2 and metalloproteinases, and their application as novel antivenoms.<br><br>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.<p /> <p>Language: en</p>",
language="en",
issn="1381-6128",
doi="10.2174/1381612824666180223172854",
url="http://dx.doi.org/10.2174/1381612824666180223172854"
}